Rogdaki, Maria http://orcid.org/0000-0003-2685-1789
Gudbrandsen, Maria http://orcid.org/0000-0002-0464-2065
McCutcheon, Robert A http://orcid.org/0000-0003-1102-2566
Blackmore, Charlotte E http://orcid.org/0000-0001-5065-625X
Brugger, Stefan
Ecker, Christine
Craig, Michael C
Daly, Eileen
Murphy, Declan G M http://orcid.org/0000-0002-6664-7451
Howes, Oliver
Funding for this research was provided by:
Wellcome Trust (200102/Z/15/Z, 094849/Z/10/Z))
Maudsley Charity (666)
RCUK | Medical Research Council (MC-A656-5QD30)
Article History
Received: 16 December 2018
Revised: 2 December 2019
Accepted: 12 December 2019
First Online: 10 January 2020
Compliance with ethical standards
:
: MR, MG, RM, CB, SB, ED have no conflict of interest to declare. OH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Astra-Zeneca, Autifony, Biogen, BMS, Eli Lilly, Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither OH or his family have been employed by or have holdings/a financial stake in any pharmaceutical company. DGMM sat on an advisory board for Roche and received an honorarium.